SLC7A1 and neoplasm: In order to determine which of the three subgroups in MAPK signaling is responsible for the carcinogenic function of SLC7A1, Western blotting results showed that the shSLC7A1 group reduced the phosphorylation of ERK in tumor cells compared with the control group and the shNC group.